Competition Bulletin March 2017
Table of Contents
| 01 | Spain / Mergers: Table of merger decisions issued by the Spanish Competition Authority (SCA) between 1 December 2016 and 7 March 2017. |
| 02 | Spain / Mergers / Healthcare: Vertical integration in the healthcare business – acquisition of QuironSalud by Fresenius (Decision of 22 December 2016). |
| 03 | Spain / Judicial activity / Parent-subsidiary relation: The Supreme Court upholds the appeal filed by a parent company fined for anticompetitive behaviour by a subsidiary (Judgment of 18 January 2016, case 2359/2013). |
| 04 | Spain / Judicial activity / Blablacar regulation: A First Instance Commercial Court dismisses the lawsuit filed against Blablacar for unfair competition stating that Blablacar is a platform that focuses exclusively on private transport and is therefore not subject to the transportation regulations (Judgment of the Commercial Court of 2 February 2017). |
| 05 | Spain / Restrictive practices investigation / Excessive prices: The SCA has initiated an investigation against Aspen Pharma for alleged excessive pricing. |
| 06 | Spain / Regulation / Public procurement: The SCA issued guidance to identify potential fraud in public procurement. |
| 07 | Spain / Judicial activity / The principle of legitimate expectations: The Spanish Supreme Court has issued a judgment regarding the interpretation of the principle of legitimate expectations. |
| 08 | Spain / Restrictive practices / Rail-cargo market: The SCA has fined several RENFE and Deutsche Bahn for blocking the liberalization of the rail-cargo market (Decision of 28 February 2017, file S/DC/0511/14 RENFE OPERADORA). |
| 09 | EU / Preliminary ruling / The SCA creation: The European Court of Justice (ECJ) rules that the creation of the current SCA breached EU law (ECJ Judgment of 19 October 2016, case C-424/15). |